Leukotriene and zafirlukast share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.100 means 10% of the combined target set is bound by both compounds. The IDF-weighted score of 0.126 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Leukotriene and zafirlukast have in common?
Leukotriene and zafirlukast share 2 molecular targets with a Jaccard similarity of 10%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Leukotriene and zafirlukast be combined?
Leukotriene and zafirlukast share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Leukotriene or zafirlukast?
Both Leukotriene and zafirlukast have substantial PubMed research. View their individual profiles for full evidence scores.